About Mirabilia Sciences Private Limited
Data last updated:
Mirabilia Sciences Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U36912GJ2013PTC076686. Its GSTIN is 24AAICM8107D1ZQ (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Mahesh Chandulal Shah and Pravinaben Maheshbhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2023, the company reported a revenue of ₹56.04 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹10,264 (net margin 0.2%) and EBITDA of ₹1.3 Lakh (EBITDA margin 2.3%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mirabiliasciences.com.
Company details
CIN history
Mirabilia Sciences has one previous CIN (Corporate Identification Number): U24233GJ2013PTC076686. The current CIN is U36912GJ2013PTC076686, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U36912GJ2013PTC076686 | Current |
| U24233GJ2013PTC076686 | Previous |
Contact details
Mirabilia Sciences Private Limited's registered office is in Surat, Gujarat. Its website is mirabiliasciences.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressB – 702 Shreeji Arcade B/H Bhulkabhavan School Anand Mahal Roa, D Adajan, Surat, Gujarat, India – 395009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mirabilia Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mirabilia Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mirabilia Sciences Private Limited, buy the company report.
Financials of Mirabilia Sciences Private Limited
FY 2023 filings availableMirabilia Sciences Private Limited reported revenue of ₹56.04 Lakh (down 32% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 32% fall in the latest year. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,264 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mirabilia Sciences Private Limited, buy the company report.
Board of directors of Mirabilia Sciences Private Limited
Mirabilia Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Chandulal Shah | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
| Pravinaben Maheshbhai Shah | Director | 24 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Mirabilia Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azishan Pharma Private Limited | ₹56.53 Lakh (FY 2018) | 12.0% | Chennai, Tamil Nadu, India | |||
| Health-Wise Medicare Private Limited | ₹56.19 Lakh (FY 2022) | 166.0% | Siliguri, West Bengal, India | |||
| Mirabilia Sciences Private Limitedthis company | ₹56.04 Lakh (FY 2023) | ₹10,264 | 0.2% | -32.0% | Surat, Gujarat, India | |
| Criswell Pharmaceuticals Private Limited | ₹55.99 Lakh (FY 2025) | 6.0% | Agra, Uttar Pradesh, India | |||
| Genuine Biolife Science Private Limited | ₹55.99 Lakh (FY 2025) | 18.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mirabilia Sciences Private Limited, buy the company report.
Auditor
Mirabilia Sciences Private Limited is audited by J N SHAH & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J N SHAH & CO | FY 2018 | 118020W |
Shareholding
The shareholding of Mirabilia Sciences Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mirabilia Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mirabilia Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mirabilia Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mirabilia Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICM8107D1ZQ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mirabilia Sciences Private Limited, buy the company report.
Recent activity
Mirabilia Sciences Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Pravinaben Maheshbhai Shah was appointed as Director on 24 Aug 2024.
Frequently asked questions
Mirabilia Sciences is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2013 (13+ years old) and is registered under CIN U36912GJ2013PTC076686.
Mirabilia Sciences has 2 current directors:
- Mahesh Chandulal Shah - Director
- Pravinaben Maheshbhai Shah - Director
The latest financial statements of Mirabilia Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Mirabilia Sciences is 24AAICM8107D1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Mirabilia Sciences is U36912GJ2013PTC076686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mirabilia Sciences was incorporated on 04 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Mirabilia Sciences by revenue are Azishan Pharma Private Limited, Health-Wise Medicare Private Limited, Criswell Pharmaceuticals Private Limited, Genuine Biolife Science Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pravinaben Maheshbhai Shah was appointed as Director on 24 Aug 2024. Jigar Maheshkumar Shah was appointed as Director on 04 Sep 2013. Mahesh Chandulal Shah was appointed as Director on 04 Sep 2013.
Mirabilia Sciences can be reached through the website mirabiliasciences.com. Its registered office is in Surat, Gujarat, India.
The registered office of Mirabilia Sciences is at B – 702 Shreeji Arcade BH Bhulkabhavan School Anand Mahal Roa, D Adajan, Surat, Gujarat, India – 395009.
Mirabilia Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.